Comparative Transcriptional Analyses in the Nucleus Accumbens Identifies RGS2 as a Key Mediator of Depression-Related...

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Major depressive disorder (MDD) affects millions globally, with higher rates in women.
• Current antidepressants are ineffective for a significant portion of patients.
• Existing animal models often fail to adequately represent female-specific aspects of depression, hindering therapeutic development.

Purpose of the Study:

• To identify stress-sensitive molecular targets in female-specific depression models.
• To find targets with translational relevance for women diagnosed with major depressive disorder.
• To investigate the role of Regulator of G protein signaling 2 (RGS2) in depression.

Main Methods:

• Utilized the California mouse social defeat model for stress exposure.
• Analyzed transcriptional profiles in the nucleus accumbens (NAc) of male and female mice.
• Compared mouse data with postmortem NAc samples from human patients with MDD.

Main Results:

• Identified Rgs2 as a transcript downregulated by social stress in female mice and women with MDD.
• RGS2 regulates neuropeptide and neurotransmitter receptor signaling.
• Overexpressing Rgs2 in the NAc reversed depression-related behaviors in stressed female mice.

Conclusions:

• RGS2 in the NAc influences anxiety- and depression-related behaviors.
• RGS2 may represent a novel therapeutic target for treatment-resistant depression in women.
• Further research is warranted to explore RGS2-based treatments for female depression.